Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients. (Record no. 19288342)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02279 a2200673 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515193813.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201003s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1098-6596 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1128/AAC.01051-09 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Marcelin, Anne-Genevieve |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20100315 |
| 245 00 - TITLE STATEMENT | |
| Title | Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Antimicrobial agents and chemotherapy |
| Date of publication, distribution, etc. | Jan 2010 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 72-7 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Anti-HIV Agents |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Resistance, Viral |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Genotype |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HIV Infections |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HIV Reverse Transcriptase |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HIV-1 |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mutation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nitriles |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Phylogeny |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pyridazines |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pyrimidines |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | RNA, Viral |
| General subdivision | biosynthesis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Reverse Transcriptase Inhibitors |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Reverse Transcriptase Polymerase Chain Reaction |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Flandre, Philippe |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Descamps, Diane |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Morand-Joubert, Laurence |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Charpentier, Charlotte |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Izopet, Jacques |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Trabaud, Mary-Anne |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Saoudin, Henia |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Delaugerre, Constance |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tamalet, Catherine |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cottalorda, Jacqueline |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bouvier-Alias, Magali |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bettinger, Dominique |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dos Santos, Georges |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ruffault, Annick |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Alloui, Chakib |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Henquell, Cecile |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rogez, Sylvie |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Barin, Francis |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Signori-Schmuck, Anne |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vallet, Sophie |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Masquelier, Bernard |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Calvez, Vincent |
| 773 0# - HOST ITEM ENTRY | |
| Title | Antimicrobial agents and chemotherapy |
| Related parts | vol. 54 |
| -- | no. 1 |
| -- | p. 72-7 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1128/AAC.01051-09">https://doi.org/10.1128/AAC.01051-09</a> |
| Public note | Available from publisher's website |
No items available.